253 results on '"SPIRONOLACTONE"'
Search Results
2. The effect of spironolactone in reducing the risk of postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery: randomized single-blind placebo-controlled study
3. Mineralocorticoid receptor blockage in kidney transplantation: too much of a good thing or not?
4. The Gut Microbiota Mediates the Protective Effects of Spironolactone on Myocardial Infarction
5. Spironolactone use and oocyte maturation in patients undergoing controlled ovarian hyperstimulation
6. Combinational Diuretics in Heart Failure
7. Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document
8. A Novel Method of the Simultaneous Determination of Spironolactone and Furosemide in Pharmaceutical Tablets
9. The effect of different treatment strategies on glycolipid metabolism disorders and cardiovascular events in primary aldosteronism
10. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management
11. To evaluate hypertrichosis with low dose oral minoxidil and spironolactone combination therapy for alopecia
12. Efficacy and safety of topical spironolactone versus topical dapsone in the treatment of acne vulgaris
13. Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis
14. The Effect of Spironolactone Loading on the Properties of 3D-Printed Polycaprolactone/Gold Nanoparticles Composite Scaffolds for Myocardial Tissue Engineering
15. A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk
16. Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
17. Pharmacokinetics of oral spironolactone in infants up to 2 years of age
18. The Microbiome and Acne: Perspectives for Treatment
19. Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study
20. Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni
21. Estimation of Two Diuretics Using Fluorescent Nitrogen Doped Carbon Quantum Dots: Application to Spiked Human Plasma and Tablets
22. SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
23. Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol
24. Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi
25. Diuretics in pediatrics
26. Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats
27. A quantitative systems pharmacology model of plasma potassium regulation by the kidney and aldosterone
28. An Update on Refractory Hypertension
29. Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT
30. Risk Stratification and Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial
31. Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronism
32. Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses
33. Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study
34. Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model
35. Evaluation of spironolactone compatibility with magnesium stearate and other lubricants in paediatric formulation using thermal and nonthermal techniques
36. Managing heart failure in dialysis patients
37. Long-term impact of spironolactone compliance on microalbuminuria in patients with primary aldosteronism
38. New Acne Therapies and Updates on Use of Spironolactone and Isotretinoin: A Narrative Review
39. Impaired Distal Tubular Acidification, Renal Cysts and Nephrocalcinosis in Monogenic Hypertension
40. Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid—a familiar foe
41. Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters
42. Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials
43. Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats
44. Insight into the Adsorption and Inhibitive Effect of Spironolactone Drug on C38 Carbon Steel Corrosion in Hydrochloric Acid Environment
45. Breast cancer and spironolactone: an observational postmarketing study
46. Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?
47. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
48. Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
49. Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression
50. Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.